RE-BVS – Piemonte Repository

Sfoglia per AUTORE
LO RE M
Collezione AOU San Luigi di Orbassano

Items : 6

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200188. doi: 10.1212/NXI.0000000000200188. Epub 20

2024
AOU San Luigi di Orbassano

Carta S; Dinoto A; Capobianco M; Valentino P; Montarolo F; Sala A; Reindl M; Lo Re M; Chiodega V; Branger P; Audoin B; Aboab J; Papeix C; Collongues N; Kerschen P; Zephir H; Créange A; Bourre B; Schanda K; Flanagan EP; Redenbaugh V; Villacieros-Álvarez J; Arrambide G; Cobo-Calvo A; Ferrari S; Marignier R; Mariotto S; Carta S; Dinoto A; et alii...

In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting. in Journal of neurology / J Neurol. 2024 Dec;271(12):7494-7501. doi: 10.1007/s00415-024-12701-w. Epub 2024 Sep 23.

2024
AOU San Luigi di Orbassano

Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;

Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Nov;46:102592. doi: 10.1016/j.msard.2020.102592. Epub 2020 Oct 21.

2020
AOU San Luigi di Orbassano

Masuccio FG; Lo Re M; Bertolotto A; Capobianco M; Solaro C;

Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod. in European journal of neurology / Eur J Neurol. 2019 Apr;26(4):667-672. doi: 10.1111/ene.13875. Epub 2018 Dec 22.

2019
AOU San Luigi di Orbassano

Montarolo F; Perga S; Martire S; Brescia F; Caldano M; Lo Re M; Panzica G; Bertolotto A;

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.

2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers. in Neurology and therapy / Neurol Ther. 2015 Dec;4(2):147-57. doi: 10.1007/s40120-015-0038-9. Epub 2015 Dec 8.

2015
AOU San Luigi di Orbassano

Lo Re M; Capobianco M; Ragonese P; Realmuto S; Malucchi S; Berchialla P; Salemi G; Bertolotto A;